A
Armando Tripodi
Researcher at University of Milan
Publications - 301
Citations - 17418
Armando Tripodi is an academic researcher from University of Milan. The author has contributed to research in topics: Prothrombin time & Thrombomodulin. The author has an hindex of 60, co-authored 278 publications receiving 14939 citations. Previous affiliations of Armando Tripodi include Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico & University of Bari.
Papers
More filters
Journal ArticleDOI
Update of the guidelines for lupus anticoagulant detection
Vittorio Pengo,Armando Tripodi,Guido Reber,Jacob H. Rand,Thomas L. Ortel,Monica Galli,de Peter Groot +6 more
TL;DR: Modalities for blood collection and processing are fully delineated and the choice of tests is limited to dRVVT and a sensitive aPTT and the interpretation of the results in general and in particular situations is reported.
Journal ArticleDOI
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
Mauro Panigada,Nicola Bottino,Paola Tagliabue,Giacomo Grasselli,Cristina Novembrino,Veena Chantarangkul,Antonio Pesenti,Flora Peyvandi,Armando Tripodi +8 more
TL;DR: The severe inflammatory state secondary to COVID‐19 leads to a severe derangement of hemostasis that has been recently described as a state of disseminated intravascular coagulation (DIC) and consumption coagulopathy, defined as decreased platelet count, increased fibrin(ogen) degradation products such as D‐dimer, as well as low fibrInogen.
Journal ArticleDOI
The Coagulopathy of Chronic Liver Disease
TL;DR: In this paper, the authors consider the evidence regarding the balance in the hemostatic system (involving coagulation, platelets, and fibrinolysis).
Journal ArticleDOI
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
Armando Tripodi,Francesco Salerno,Veena Chantarangkul,Marigrazia Clerici,Massimo Cazzaniga,Massimo Primignani,Pier Mannuccio Mannucci +6 more
TL;DR: In this paper, the authors used a thrombin generation test to investigate the coagulation function in patients with cirrhosis, and they found that the reduction of pro-coagulant factors in patients had little impact on the reduction in anticoagulants.
Journal ArticleDOI
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
Armando Tripodi,Massimo Primignani,Veena Chantarangkul,Alessandra Dell'Era,Marigrazia Clerici,Roberto de Franchis,Massimo Colombo,Pier Mannuccio Mannucci +7 more
TL;DR: The hypercoagulability of plasma from patients with cirrhosis appears to result from increased levels of factor VIII and decreased levels of protein C-typical features of patients with Cirrhosis, which might explain the risk for venous thromboembolism in patients with chronic liver disease.